Policy / Pricing FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars Big Molecule WatchThe U.S.Policy / PricingRead full story pharminent April 22, 2026 (Last updated: April 23, 2026) Big Molecule Watch The U.S. Policy / PricingRead full story Post navigation Previous: Medicare weight loss drug pilot on ice as insurers decline to contributeNext: AbbVie makes record investment in North Carolina plant Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
